Our Executive Comittee
Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer
Chief People & Organization Officer
Chief Digital Officer
James (Jay) Bradner, M.D.
President of the Novartis Institutes for BioMedical Research (NIBR)
CEO, Novartis Pharmaceuticals
Chief Financial Officer
Shannon Thyme Klinger
Group General Counsel
Steffen Lang, Ph.D.
Global Head of Novartis Technical Operations
Klaus Moosmayer, Ph.D.
Chief Ethics, Risk and Compliance Officer
Susanne Schaffert,1 Ph.D.
CEO, Novartis Oncology
John Tsai, M.D.
Head of Global Drug Development and Chief Medical Officer
Head of Novartis Business Services (NBS)
1 Elizabeth (Liz) Barrett stepped down as CEO of Novartis Oncology and as a member of the Executive Committee of Novartis on December 31, 2018.